γδ T cells in cancer
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
With the promise of T cell-based therapy for cancer finally becoming reality, this Review focuses on the less-studied γδ T cell lineage and its diverse responses to tumours. γδ T cells have well-established protective roles in cancer, largely on the basis of their potent cytotoxicity and interferon-γ production. Besides this, recent studies have revealed a series of tumour-promoting functions that are linked to interleukin-17-producing γδ T cells. Here, we integrate the current knowledge from both human and mouse studies to highlight the potential of γδ T cell modulation to improve cancer immunotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“γδ T cells can have either protective roles or tumor-promoting functions in cancer; tumor-promoting activities of γδ T cells have been ascribed to distinct mechanisms in different types of cancers (Daley et al., 2016; Silva-Santos et al., 2015).”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Silva-Santos et al., 2015
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,118
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C.-S., Verstegen, N. J. M., Ciampricotti, M., Hawinkels, L. J. A. C., Jonkers, J., et al. (2015) · Nature · doi:10.1038/nature14282 · Cited by 1,703
Mittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Immune adaptations that maintain homeostasis with the intestinal microbiota
Hooper, L. V., & Macpherson, A. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2710 · Cited by 1,454
Six-of-the-best: unique contributions of γδ T cells to immunology
Vantourout, P., & Hayday, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3384 · Cited by 1,232
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Research works printed but not linked: 1
- Gu, S., Nawrocka, W. & Adams, E. J. Sensing of pyrophosphate metabolites by Vγ9Vδ2 T cells. Front. Immunol. 5, 688 (2014).
Cited by
Items 301–400 of 593
Age‐related changes in lymphocyte subpopulations in healthy Thai children
Lerkvaleekul, B., Apiwattanakul, N., Klinmalai, C., Hongeng, S., & Vilaiyuk, S. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23156 · Cited by 17
Singh, P., Száraz‐Széles, M., Mezei, Z. A., Baráth, S., & Hevessy, Z. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5a1121-583rr · Cited by 17
Audemard‐Verger, A., Rivière, M., Durand, A., Peranzoni, E., Guichard, V., Hamon, P., Bonilla, N., Guilbert, T., Boissonnas, A., Auffray, C., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700430 · Cited by 17
Revisiting the Role of γδ T Cells in Anti-CMV Immune Response after Transplantation
Gaballa, A., Alagrafi, F., Uhlin, M., & Stikvoort, A. (2021) · Viruses · doi:10.3390/v13061031 · Cited by 17
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Khurana, A., & Lin, Y. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00920-6 · Cited by 17
Bibliometric Analysis of γδ T Cells as Immune Regulators in Cancer Prognosis
Liu, B., He, X., Wang, Y., Huang, J.-W., Zheng, Y.-B., Li, Y., & Lu, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.874640 · Cited by 26
“example, the Vd2 cell subset inhibits bacterial infection and tumor progression (6, 7).”
BackgroundThe potential role of the thymus in immunotherapies for acute myeloid leukemia
Hino, C., Xu, Y., Xiao, J., Baylink, D. J., Reeves, M. E., & Cao, H. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1102517 · Cited by 21
Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity
de Araújo, N. D., Magalhães-Gama, F., Barros, M. D. S., Pereira-Ribeiro, T. L., Alves-Hanna, F. S., Xábregas, L. A., Tarragô, A. M., Malheiro, A., & Costa, A. G. (2021) · Journal of Immunology Research · doi:10.1155/2021/6633824 · Cited by 20
Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics
Shu, Y., Peng, J., Feng, Z., Hu, K., Li, T., Zhu, P., Cheng, T., & Liang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.941724 · Cited by 16
de Witte, M. A., Kuball, J. H. E., & Miller, J. S. (2017) · Current Stem Cell Reports · doi:10.1007/s40778-017-0106-4 · Cited by 18
Lin, T.-H., Su, H., Kang, H., & Chang, T.-H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102219 · Cited by 18
“coli in mice models via intranasal inoculation leads to suppression of allergic airway inflammation by recruited γδ T cells (a subset of T cells with potent cytotoxicity and interferon-γ production [98]), and dampening of DC function in the lung, thus decreasing the effectiveness of presenting antigen to effector T ce…”
BackgroundBispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells
Yang, R., Shen, S., Gong, C. L., Wang, X., Luo, F., Luo, F., Lei, Y., Wang, Z., Xu, S.-S., Ni, Q., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654080 · Cited by 21
“This gene variation-ignored killing mechanism of our approach further proved the potential anti-tumor nature of the Vg2Vd2 T cells (35, 36, 45).”
BackgroundRosso, D. A., Rosato, M., Iturrizaga, J., González, N., Shiromizu, C. M., Keitelman, I. A., Coronel, J. V., Gómez, F. D., Amaral, M. M., Rabadán, A. T., et al. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03787-7 · Cited by 17
MicroRNA‐181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2
Gordino, G., Costa-Pereira, S., Corredeira, P., Alves, P., Costa, L., Gomes, A. Q., Silva‐Santos, B., & Ribot, J. C. (2021) · EMBO Reports · doi:10.15252/embr.202052234 · Cited by 18
“This urges the development of alternative treatments for advanced stages of the disease. cd T cells possess multiple anti-tumor characteristics, making them promising candidates to be used in cellular and combination therapies (Gentles et al , 2015; Silva-Santos et al , 2015, 2019).”
Self-citationRafia, C., Loizeau, C., Renoult, O., Harly, C., Pecqueur, C., Joalland, N., & Scotet, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1066336 · Cited by 16
Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T Cells
Douguet, L., Cherfils‐Vicini, J., Bod, L., Lengagne, R., Gilson, É., & Prévost‐Blondel, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165639 · Cited by 18
Ribeiro, S. T., Tesio, M., Ribot, J. C., Macintyre, E. A., Barata, J. T., & Silva‐Santos, B. (2016) · Leukemia · doi:10.1038/leu.2016.363 · Cited by 17
Self-citationApoptosis Induced via Gamma Delta T Cell Antigen Receptor “Blocking” Antibodies: A Cautionary Tale
Dutta, I., Postovit, L.-M. M., & Siegers, G. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00776 · Cited by 16
Bian, Z., Xu, L., Fu, Q., Huo, M.-R., Liu, L., Zhao, X., Huang, X., & Liu, J. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.10.027 · Cited by 16
A comparative view on vitamin C effects on αβ- versus γδ T-cell activation and differentiation
Peters, C., Kouakanou, L., & Kabelitz, D. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr1219-245r · Cited by 17
The role and significance of the PI3K/Akt-mTOR signaling pathway in infectious diseases
Sheng, G., Li, C., Liu, D., Wang, W., Pang, N., & Zhang, Z. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1782712 · Cited by 15
Dannebaum, R., Suwalski, P., Asgharian, H., Du, Z. G., Lin, H., Weiner, J. M., Holtgrewe, M., Thibeault, C., Müller, M., Wang, X., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101438 · Cited by 18
An optimized cultivation method for future in vivo application of γδ T cells
Bold, A., Gross, H., Holzmann, E., Knop, S. T., Hoeres, T., & Wilhelm, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1185564 · Cited by 15
γδ T cells: Major advances in basic and clinical research in tumor immunotherapy
Zhao, Y., Dong, P., He, W., Zhang, J., & Chen, H. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002781 · Cited by 15
Function of gamma delta (γδ) T cell in cancer with special emphasis on cervical cancer
Patra, S., Ghosal, S., Shand, H., Mondal, R., Rath, A., Jana, S. K., & Ghorai, S. (2023) · Human Immunology · doi:10.1016/j.humimm.2023.110724 · Cited by 15
Çapik, Ö., & Karataş, Ö. F. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01042-z · Cited by 16
“These major histocompatibility complex restriction and co-stimulation-independent property make γδ T cells good candidates for impressive tumor immunotherapy [40, 47, 48, 70].”
Song, Y., Zhu, Y., Hu, B., Liu, Y., Lin, D., Jin, Z., Yin, Z., Dong, C., Wu, D., & Liu, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.558143 · Cited by 15
“However, gdT cells have also been reported to promote tumor growth by producing IL-17 (18, 19).”
BackgroundHudeček, R., Kohlová, B., Sisková, I., Piskáček, M., & Knight, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.752646 · Cited by 15
Huang, S., Tan, Y., & Zhou, G. (2023) · Biomedicines · doi:10.3390/biomedicines11030955 · Cited by 16
Molecular imaging of innate immunity and immunotherapy
Xia, W., Singh, N., Goel, S., & Shi, S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114865 · Cited by 16
The Ins and Outs of Chemokine-Mediated Immune Cell Trafficking in Skin Cancer
Yam, A. O. W., & Chtanova, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00386 · Cited by 16
Recent advances in understanding the development and function of γδ T cells
Contreras, A. V., & Wiest, D. L. (2020) · F1000Research · doi:10.12688/f1000research.22161.1 · Cited by 15
IL-17A-producing γδ T cells promote liver pathology in acute murine schistosomiasis
Sun, L., Gong, W., Shen, Y., Liang, L., Zhang, X., Li, T., Chen, T. T., Hu, Y., & Cao, J. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04200-4 · Cited by 15
Andreu‐Ballester, J. C., Galindo-Regal, L., Hidalgo-Coloma, J., Cuéllar, C., García‐Ballesteros, C., Hurtado, C., Uribe, N., Martín, M. D. C., Jiménez, A. I., López-Chuliá, F., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243545 · Cited by 16
“This is of enormous importance, since it suggests the fundamental role of γδ T cells in avoiding the invasion of the tumour via the blood to other body locations and therefore, a fundamental role in avoiding metastasis [24].”
BackgroundStrijker, J. G. M., Pscheid, R., Drent, E., van der Hoek, J. J. F., Koopmans, B., Ober, K., van Hooff, S. R., Kholosy, W. M., Cornel, A. M., Coomans, C., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11090923 · Cited by 16
Immunosuppressive γδ T cells foster pancreatic carcinogenesis
Mondragón, L., Kroemer, G., & Galluzzi, L. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1237328 · Cited by 17
Cheema, A. Y., Ali, H. M., Bibi, M., Aslam, M. F., Thiagarajan, P. S., Shahid, D., Munir, M., Najam, A., Raza, S., & Anwer, F. (2025) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2025.09.044 · Cited by 21
Chemokines that govern T cell activity in tumors
Mempel, T. R., & Malehmir, M. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102510 · Cited by 15
Wen, R., Li, B., Wu, F., Mao, J., Azad, T., Wang, Y., Zhu, J., Zhou, X. Y., Xie, H., Qiu, X., et al. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103859 · Cited by 16
IL-17A–Producing γδT Cells Inhibit the Formation of Malignant Pleural Effusions
Wei, X., Pei, X., Liu, Y., Wu, X., Shi, H., & Zhou, Q. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0201oc · Cited by 14
Harmon, N. M., Poe, M. M., Huang, X., Singh, R., Foust, B. J., Hsiao, C. C., Wiemer, D. F., & Wiemer, A. J. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00408 · Cited by 14
Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy
Gaballa, A., Arruda, L. C. M., & Uhlin, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.971709 · Cited by 15
“The direct cytotoxic effects can be executed through the death receptors (FAS/FAS ligand and TRAIL/TRAIL receptor) triggering target cell apoptosis and/or through perforin/granzyme mediated tumor cell lysis (34, 46).”
BackgroundMyeloid-derived suppressor cells in head and neck squamous cell carcinoma
He, J.-Y., Huo, F., Tang, H., Liu, B., & Bu, L. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2022.11.002 · Cited by 15
Silva‐Santos, B., & Strid, J. (2017) · Nature Immunology · doi:10.1038/ni.3705 · Cited by 14
Self-citationClark, K. R., Tong, W. L., Callahan, B. M., Yavorski, J. M., Tu, Y. N., & Blanck, G. (2018) · International Journal of Immunogenetics · doi:10.1111/iji.12409 · Cited by 14
Emerging role of γδ T cells in protozoan infection and their potential clinical application
Kumar, A., Singh, B., Tiwari, R., Singh, V. K., Singh, S. S., Sundar, S., & Kumar, R. (2022) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2022.105210 · Cited by 14
Simões, C., Silva, I., Carvalho, A., Silva, S., Santos, S. A., Marques, G., Ribeiro, A. B., Roque, A. I., Carda, J. P., Sarmento‐Ribeiro, A. B., et al. (2018) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21645 · Cited by 14
“However, due to the lack of suitable protocols for ex vivo expansion to numbers suitable for adoptive cell transfer and Vδ2 T cells’ tendency for exhaustion, interest rose regarding the Vδ1 subset (8).”
BackgroundBao, W., Qu, X., Wang, Y., Huang, D., Zhang, H., Dong, M., Sun, H., Yang, Z., & Li, X. (2026) · MedComm · doi:10.1002/mco2.70599 · Cited by 15
“…encompasses MHC-independent nonpeptide ligands upregulated during cellular stress responses. γδ T cells exert their antitumor cytotoxicity through multiple effector mechanisms, predominantly through coordinated secretion of IFN-γ together with perforin and granzyme family proteins [ 270 ].”
Autoimmunity and Carcinogenesis: Their Relationship under the Umbrella of Autophagy
Műzes, G., & Sípos, F. (2023) · Biomedicines · doi:10.3390/biomedicines11041130 · Cited by 15
Long noncoding RNA TANCR promotes γδ T cells activation by regulating TRAIL expression in cis
Yang, C. H., Feng, T., Lin, F., Gong, T., Yang, S., Tao, Y., & Li, H. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00383-6 · Cited by 13
Zhang, H., Zhu, T., Fu, R., Yang, P., Peng, J., Xu, W., Wang, H., Li, S., Shu, Z., Yin, Y., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.06.015 · Cited by 15
Cui, K., Mei, X., & Cheng, M. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03742-z · Cited by 14
Schuler, L. A., & Murdoch, F. E. (2021) · Cancers · doi:10.3390/cancers13153725 · Cited by 14
Kolbe, K., Wittner, M., Hartjen, P., Hüfner, A.-D., Degen, O., Ackermann, C., Cords, L., Stellbrink, H., Haag, F., & Wiesch, J. S. Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867167 · Cited by 13
The different facets of heme-oxygenase 1 in innate and adaptive immunity
Silva, R. C. M. C., Vasconcellos, L. R. C., & Travassos, L. H. (2022) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-022-01087-z · Cited by 14
“γδ T cells can be considered part of adaptive or innate immunity, depending on their function and localization, and do express clonally rearranged T cell receptors (TCRs) [36], but these cells will not be discussed in this review.”
BackgroundPernold, C. P. S., Lagumdzic, E., Stadler, M., Mair, K. H., Jäckel, S., Schmitt, M. W., Ladinig, A., Knecht, C., Dürlinger, S., Kreutzmann, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1003986 · Cited by 14
Martín‐Martín, L., Gutiérrez-Herrero, S., Herrero, M., Martı́n, A., Yeguas, A., Martín‐López, A. Á., López‐Corral, L., Pérez‐López, E., García‐Blázquez, M., Sanchez-Guijo, F. M., et al. (2024) · Blood Cancer Journal · doi:10.1038/s41408-024-01065-z · Cited by 13
“…be not only due to their potent cytotoxic ability and proven antitumor activity [10], even in the absence of HLA-mediated antigen presentation [11, 12], but also to their ability to migrate from blood to peripheral tissues where extranodal involvement by lymphoma cells frequently occurs in…”
Jacoby, E., Varda‐Bloom, N., Goldstein, G., Hutt, D., Churi, C., Vernitsky, H., Toren, A., & Bielorai, B. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26839 · Cited by 13
Sugie, T., Suzuki, E., Yamauchi, A., Yamagami, K., Masuda, N., Gondo, N., Sumi, E., Ikeda, T., Tada, H., Uozumi, R., et al. (2018) · The Breast · doi:10.1016/j.breast.2017.12.017 · Cited by 14
Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches
Sanz, M., Mann, B. T., Chitrakar, A., & Soriano-Sarabia, N. (2022) · Cells · doi:10.3390/cells11223572 · Cited by 18
“γδ T cells are innate-like immune effectors with a critical role linking innate and adaptive immune responses owing to their unique properties [1,2].”
BackgroundIL-17–producing γδ T cells in the tumor microenvironment promote radioresistance in mice
Deng, Y., Liu, X., Yang, X., Wei, W., Wang, J., Yang, Z., Sun, Y., Hu, Y. P., Zhang, H., Wang, Y., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci193945 · Cited by 12
“The other subset predominantly secretes IL-17, which promotes the recruitment of MDSCs and Tregs, facilitates angiogenesis, and suppresses antitumor immunity (13).”
Boosting the Immune System for HIV Cure: A γδ T Cell Perspective
Mann, B. T., Sambrano, E., Maggirwar, S. B., & Soriano-Sarabia, N. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00221 · Cited by 12
“Since their discovery in the 1980’s, γδ T cells have been shown to contribute to tumor surveillance, fighting infectious disease, and autoimmunity (Tanaka, 2006; Kabelitz, 2011; Vantourout and Hayday, 2013; Silva-Santos et al., 2015; Lawand et al., 2017).”
BackgroundDecrease of perforin positive CD3+γδ-T cells in patients with obstructive sleep disordered breathing
Staats, R., Rodrigues, R., Barros, A., Bacelar–Nicolau, L., Aguiar, M., Fernandes, D., Moreira, S., Simões, A. E. S., Silva‐Santos, B., Rodrigues, J. V., et al. (2017) · Sleep And Breathing · doi:10.1007/s11325-017-1602-6 · Cited by 12
Self-citationJoalland, N., & Scotet, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00992 · Cited by 13
The capacity of CD4+ Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56
Olofsson, G. H., Pedersen, S. R., Aehnlich, P., Svane, I. M., Idorn, M., & Straten, P. T. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.02.003 · Cited by 12
Cao, W., Zhou, W., Li, M., Zhang, Z., Zhang, X., Yang, K., Yang, S., Cao, G., Chen, B., & Xiong, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951135 · Cited by 13
Teo, H. Y., Song, Y., Yong, K. S. M., Liu, Y., Mei, Y., Hanafi, Z. B., Zhu, Y., Chua, Y. L., Gascoigne, N. R. J., Chen, Q., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0952 · Cited by 12
Horenstein, A. L., Morandi, F., Bracci, C., Pistoia, V., & Malavasi, F. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.11.007 · Cited by 12
Tumor microenvironment: the formation of the immune profile
Олейник, Е. К., Шибаев, М. И., Ignatiev, K. S., Олейник, В. М., & Жулай, Г. А. (2020) · Medical Immunology (Russia) · doi:10.15789/1563-0625-tmt-1909 · Cited by 12
Proteogenomic insights into the biology and treatment of pan-melanoma
Hang, X., Luo, R., Wang, Y., Yang, B., Xu, S., Huang, W. C., Tang, S., Fang, R., Chen, L., Zhu, N., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00688-7 · Cited by 13
“A protumor role for IL-17-producing Tgd cells was reported in human cancer, and the extent of IL-17-producing Tgd cell in fi ltration positively correlated with the clinical stage of the disease 59 .”
Douguet, L., Bod, L., Démolis, L. L., Lengagne, R., Kato, M., Couillin, I., & Prévost‐Blondel, A. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1484979 · Cited by 13
Zhang, M., Xue-ling, L., Wei, C., & Li, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.12188 · Cited by 11
“These cells can exert cytotoxic effects against malignant tumors through participating in immune surveil‐ lance and tumor cell elimination (7).”
BackgroundCoronado, E., Yáñez, Y., Vidal, E., Rubio, L., Vera-Sempere, F. J., Martínez, A. J. C., Panadero, J., Cañete, A., Ladenstein, R. L., Castel, V., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12868 · Cited by 11
Phosphoantigen-Stimulated γδ T Cells Suppress Natural Killer–Cell Responses to Missing-Self
Walwyn-Brown, K., Pugh, J. L., Cocker, A. T. H., Beyzaie, N., Singer, B. B., Olive, D., Guethlein, L. A., Parham, P., & Djaoud, Z. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0696 · Cited by 11
Haploidentical γδ T Cells Induce Complete Remission in Chemorefractory B-cell Non-Hodgkin Lymphoma
Bold, A., Gaertner, J., Bott, A., Mordstein, V., Schaefer‐Eckart, K., & Wilhelm, M. (2023) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000450 · Cited by 11
Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy
Wang, L., Li, J., Xuan, Y., Zhang, J., Wang, X., Hu, W., & Xiu, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1554541 · Cited by 13
Innate immune cells in chimeric antigen receptor therapy
Jassaud, M., Ziane-Chaouche, L., Duhamel, M., & Salzet, M. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.10.003 · Cited by 10
“95 The development of CAR-γδ T cells aims to enhance their tumor-targeting capabilities while maintaining their natural advantages.”
Immune dysregulation in endometriosis: the T cell perspective
Sisnett, D. J., Zutautas, K. B., Vo, D. H. N., Ravishanker, A., Holmes, J. P., Wodz, A., & Tayade, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1712360 · Cited by 12
Gamma/Delta T-Cells Enhance Carboplatin-induced Cytotoxicity Towards Advanced Bladder Cancer Cells
PAN, Y., Chiu, Y., Chiu, S., Cho, D., Lee, L.-M., Wen, Y., Whang‐Peng, J., Hsiao, C., & Shih, P. (2020) · Anticancer Research · doi:10.21873/anticanres.14525 · Cited by 10
Chang, Y., Chiang, Y., Hsu, K., Chuang, C., Kao, C.-W., Chang, Y., Chang, M., Lim, K., Cheng, H.-I., Hsu, Y.-N., et al. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00572-7 · Cited by 10
Unraveling the secrets of γδ T cells with single-cell biology
Sagar (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad131 · Cited by 11
Pernold, C. P. S., Lagumdzic, E., Stadler, M., Dolezal, M., Jäckel, S., Schmitt, M. W., Mair, K. H., & Saalmüller, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1327776 · Cited by 11
Wang, X., Wang, H., Lu, Z., Liu, X., Chai, W., Wang, W., Feng, J., Shen, Y., Yang, W., Cheng, H., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-1509 · Cited by 10
“The immunocompetence of γδ T cells is usually independent of tumor-associated antigens and MHC expression; these cells are characterized by strong cytotoxicity toward various tumors in experimental and clinical settings (65, 66).”
Immunologic Targeting of Cancer Stem Cells
Zhang, J., Li, Q., & Chang, A. E. (2019) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2019.02.010 · Cited by 13
The role of Raptor in lymphocytes differentiation and function
Tang, J., Yang, L., Guan, F., Miller, H., Câmara, N. O. S., James, L. K., Benlagha, K., Kubo, M., Heegaard, S., Lee, P. P. W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1146628 · Cited by 10
γδ cell-based immunotherapy for cancer
Presti, E. L., Corsale, A. M., Dieli, F., & Meraviglia, S. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1634050 · Cited by 11
“However, the clinical relevance of tumor-infiltrating γδ T lymphocytes has remained obscure because of inconsistent results; in fact, the relative frequencies of tumor-infiltrating γδ T cells, as assessed by either immunohistochemistry or flow cytometry, have been reported to correlate with tumor remission, or with tu…”
BackgroundResultMa, Y., Ou, J., Lin, T., Chen, L., Wang, J., Qiao, D., Lai, S., Duan, C., Cheng, Y., Chang, R., et al. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1765375 · Cited by 10
Positron Emission Tomography Probes for Imaging Cytotoxic Immune Cells
Amgheib, A., Fu, R., & Aboagye, E. O. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102040 · Cited by 9
“γδ T Cell Therapy Another adoptive cell therapy that has gained considerable attention as an attractive candidate for cancer immunotherapy is the use of γδ T cells, which are a minor population of peripheral lymphocytes [44].”
BackgroundZappa, E., Vitali, A., Anders, K., Molenaar, J. J., Wienke, J., & Künkele, A. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113347 · Cited by 10
“V δ 1-containing T cells are abundant in healthy epithelia and in tumour infiltrates [194], whereas the V γ 9V δ 2 subtype is rich in the peripheral blood [195].”
Pu, Y., Yang, G., Zhou, Y., Pan, X., Guo, T., & Chai, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112198 · Cited by 9
Diverse Subsets of γδT Cells and Their Specific Functions Across Liver Diseases
Zhan, C., Peng, C., Wei, H., Wei, K., Ou, Y., & Zhang, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062778 · Cited by 10
Human γδ T cells: rapid, stable and clonally reactive
Hovav, A. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.33 · Cited by 9
In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity
Liu, Y., Han, Y., Zeng, S., & Shen, H. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00565-w · Cited by 11
Sato, Y., Mori, K., Hirano, K., Yagi, K., Kobayashi, Y., Nagaoka, K., Hosoi, A., Matsushita, H., Kakimi, K., & Seto, Y. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.02.002 · Cited by 9
Madhok, A., Bhat, S. A., Philip, C. S., Sureshbabu, S. K., Chiplunkar, S. V., & Galande, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660361 · Cited by 9
The Role of γδ T-Lymphocytes in Glioblastoma: Current Trends and Future Directions
Ahmedna, T. S., Khela, H. S., Weber-Levine, C., Azad, T. D., Jackson, C. M., Gabrielson, K. L., Bettegowda, C., & Rincón-Torroella, J. (2023) · Cancers · doi:10.3390/cancers15245784 · Cited by 9
“Second, most clinical trials of cancer treatment with γδ T cells have used the V δ 2 + type, particularly the V γ 9V δ 2 subset, due to their higher abundance relative to other types, leaving the V δ 1 and V δ 3 chains under-investigated [41].”
BackgroundSiegers, G. M., Dutta, I., Kang, E. Y., Huang, J., Köbel, M., & Postovit, L.-M. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01287 · Cited by 9
“Gamma delta T cells kill a wide range of malignancies (6).”
BackgroundLymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities
Presti, E. L., Dieli, F., & Meraviglia, S. (2021) · Vaccines · doi:10.3390/vaccines9060562 · Cited by 10
“Many studies in the oncology field have enabled the creation of new therapies based on the use of γδ T cells [55,56].”
BackgroundWang, Y., Li, X., Huang, Y., Gang, Q., Liu, M., Zhang, H., Shen, S., Yao, Q., & Zhang, J. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s456452 · Cited by 11
“M1 macrophages and γδ T cells have been shown to inhibit tumor cell growth and induce tumor cell death, resulting in improved patients’ outcomes, 37–39 while Tregs promote tumor progression via immune inhibitory.”
BackgroundFrom innate-like to innate: the next wave of off-the-shelf CAR immunotherapies
Feng, Y., Yang, Z., Zhou, Y., LIANG, Y., & Zhao, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1691743 · Cited by 8
Metadata
- Authors
- Silva-Santos, B., Serre, K., & Norell, H.
- Affiliations
- University of Lisbon (PT)
- Corresponding author
- Serre, Karine
- Venue
- Nature reviews. Immunology
- Published
- 2015-10-09
- Volume
- 15
- Issue
- 11
- Pages
- 683-691
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2183777144
- Cited by
- 565
- References
- 95
- Citations by year
- 2026: 30 · 2025: 43 · 2024: 39 · 2023: 60 · 2022: 72 · 2021: 59 · 2020: 63 · 2019: 54 · 2018: 55 · 2017: 56 · 2016: 33
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- γδ T cells, cancer immunotherapy, tumour immunity, cytotoxicity, interferon-gamma, IL-17, T cell regulation
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Humans, Neoplasms, T-Lymphocytes, Receptors, Antigen, T-Cell, gamma-delta, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.